Chinese journal of cancer research = Chung-kuo yen cheng yen chiu (Chin J Cancer Res)

Journal PubWeight™ 410.04‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Annual report on status of cancer in China, 2010. 2014 4.69
2 Annual report on status of cancer in China, 2011. 2015 4.62
3 Report of incidence and mortality in China cancer registries, 2009. 2013 2.88
4 National cancer incidence and mortality in China, 2012. 2016 1.90
5 Cancer incidence and mortality in china, 2006. 2011 1.50
6 Report of incidence and mortality in china cancer registries, 2008. 2012 1.49
7 Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories. 2014 1.41
8 Cancer incidence and mortality in china, 2007. 2012 1.37
9 Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. 2013 1.23
10 Clinicopathological analysis of metaplastic meningioma: report of 15 cases in Huashan Hospital. 2013 1.21
11 Incidence and mortality of colorectal cancer in China, 2011. 2015 1.20
12 Cancer statistics: updated cancer burden in China. 2015 1.20
13 Physical scientists research biomedicine: a call for caution. 2015 1.14
14 Huang's three-step maneuver for laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer. 2014 1.14
15 Clinical significance of stanniocalcin expression in tissue and serum of gastric cancer patients. 2014 1.11
16 Gambogic acid induces mitochondria-dependent apoptosis by modulation of Bcl-2 and Bax in mantle cell lymphoma JeKo-1 cells. 2013 1.07
17 Unusual presentation of cutaneous metastasis from bladder urothelial carcinoma. 2013 1.07
18 Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications. 2014 1.01
19 Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer. 2012 1.01
20 Laparoscopic approach for hepatocellular carcinoma: where is the limit? 2014 1.00
21 Oral cancer incidence and mortality in China, 2011. 2015 1.00
22 Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA. 2013 0.97
23 Prevalence of HPV Infection And Cervical Intraepithelial Neoplasia And Attitudes towards HPV Vaccination among Chinese Women Aged 18-25 in Jiangsu Province. 2011 0.97
24 Incidence and mortality rate of esophageal cancer has decreased during past 40 years in Hebei Province, China. 2015 0.96
25 Comparison of RECIST version 1.0 and 1.1 in assessment of tumor response by computed tomography in advanced gastric cancer. 2013 0.96
26 microRNAs and ceRNAs: RNA networks in pathogenesis of cancer. 2013 0.96
27 Pancreatic cancer incidence and mortality patterns in China, 2011. 2015 0.95
28 Evolving thoracic surgery: from open surgery to single port thoracoscopic surgery and future robotic. 2013 0.94
29 Over-expression of Metastasis-associated in Colon Cancer-1 (MACC1) Associates with Better Prognosis of Gastric Cancer Patients. 2011 0.94
30 Individualized Chemotherapy in Advanced NSCLC Patients Based on mRNA Levels of BRCA1 and RRM1. 2012 0.94
31 Multiple primary malignancies: a report of two cases. 2014 0.93
32 MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma. 2014 0.93
33 Expressions of Osteopontin (OPN), ανβ3 and Pim-1 Associated with Poor Prognosis in Non-small Cell Lung Cancer (NSCLC). 2012 0.92
34 Th22 cells are associated with hepatocellular carcinoma development and progression. 2014 0.92
35 Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology. 2016 0.91
36 Role of contrast-enhanced ultrasonography in percutaneous radiofrequency ablation of liver metastases and efficacy evaluation. 2013 0.91
37 Differential expression of serum miR-126, miR-141 and miR-21 as novel biomarkers for early detection of liver metastasis in colorectal cancer. 2014 0.91
38 Single-nucleotide polymorphism associations for colorectal cancer in southern chinese population. 2012 0.91
39 Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study. 2012 0.91
40 Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer. 2013 0.91
41 Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells. 2013 0.91
42 TPX2 knockdown suppressed hepatocellular carcinoma cell invasion via inactivating AKT signaling and inhibiting MMP2 and MMP9 expression. 2014 0.90
43 Time trends of cancer incidence in urban beijing, 1998-2007. 2011 0.90
44 Overexpression of Gli1 in cancer interstitial tissues predicts early relapse after radical operation of breast cancer. 2012 0.90
45 Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression. 2014 0.89
46 Pancreatic cancer surgery: past, present, and future. 2015 0.89
47 Spleen-preserving splenic lymph node dissection in radical total gastrectomy. 2013 0.89
48 Nonintubated video-assisted thoracic surgery under epidural anesthesia-Encouraging early results encourage randomized trials. 2014 0.89
49 NRS2002 assesses nutritional status of leukemia patients undergoing hematopoietic stem cell transplantation. 2012 0.89
50 Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy. 2012 0.89
Next 50